Get a glimpse into our company and investor data—powered by the PitchBook Platform
Distribution rights in the United States of uridine triacetate drug. The drug is used for treating patients at risk of serious toxicity following an overdose of 5-flourouracil.
This information is reserved for PitchBook Platform users. To explore Wellstat Therapeutics Corporation (rights to uridine triacetate)‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.